From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 294,186 shares, representing 0.87% for KRW 2,998.6 million under the buyback announced on September 20, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,210 KRW | -2.82% | -4.75% | -29.27% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.27% | 156M | |
+10.10% | 114B | |
+12.93% | 107B | |
-5.20% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.64% | 17.51B | |
-39.36% | 17.17B | |
+7.04% | 14.14B | |
+34.65% | 12.2B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.